Skip to main content

Table 4 The pooled prevalence of different genotypes of HPV among HIV-infected women in LMICs

From: Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis

HPV genotypes Random effects pooled %ES (95% CI) No of studies χ2 DF p value I2 (%)
16 20 (12.0–28-0) 13 814.56 12 < 0.001 98.53
18 15 (10.0–20.0) 12 390.48 11 < 0.001 97.18
26 4 (2.0–5.0) 3 2.12 2 0.35 5.68
31 11 (7.0–14.0) 11 260.91 10 < 0.001 96.17
33 8 (5.0–11.0) 8 72.55 7 < 0.001 90.35
35 10 (6.0–14.0) 9 120.78 8 < 0.001 93.38
39 5 (3.0–8.0) 7 53.68 6 < 0.001 88.82
45 7 (5.0–10.0) 10 114.13 9 < 0.001 92.11
51 8 (5.0–10.0) 9 37.74 8 < 0.001 78.80
52 13 (9.0–18.0) 9 157.30 8 < 0.001 94.91
53 10 (5.0–16.0) 7 83.80 6 < 0.001 92.84
56 6 (4.0–9.0) 7 45.42 6 < 0.001 86.79
58 11 (8.0–14.0) 11 94.54 10 < 0.001 89.42
59 5 (3.0–7.0) 7 66.49 6 < 0.001 90.98
66 8 (3.0–12.0) 5 44.36 4 < 0.001 90.98
67 2 (1.0–3.0) 2   1   
68 6 (3.0–10.0) 6 74.28 5 < 0.001 93.27
69 4 (2.0–5.0) 2   1   
70   1     
73 5 (2.0–8.0) 4 12.73 3 0.01 76.42
82 5 (3.0–6.0) 4 3.54 3 0.32 15.21
  1. HPV, human papillomavirus; χ2, heterogeinity chi-square; DF, degree of freedom; I2, heterogeneity; ES, effect size, CI, confidence interval
\